期刊
IMMUNOLOGIC RESEARCH
卷 47, 期 1-3, 页码 257-264出版社
HUMANA PRESS INC
DOI: 10.1007/s12026-009-8157-y
关键词
Plasmapheresis; Intravenous immunoglobulin; IVIG; ABO incompatible; Positive crossmatch; Kidney; Transplantation; Kidney paired donation
类别
Human leukocyte antigen (HLA) sensitization and ABO incompatibility continue to pose significant barriers to further expansion of live donor renal transplantation. However, the recent development of effective desensitization protocols and creative paired donation strategies demonstrates that the presence of circulating donor HLA-specific antibodies and the use of ABO incompatible organs should no longer be considered contraindications for renal transplantation. It is estimated that as many as 6,000 patients on the kidney transplant waiting list have incompatible living donors and could benefit from these treatments. Furthermore, as our understanding of these treatment modalities has improved, it is now possible to predict whether desensitization, kidney paired donation or a combination of both will provide an individual patient with their best chance for successful renal transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据